Neuromyelitis Optica

Neuromyelitis optica (NMO) is a rare, lifelong autoimmune disease where your body's immune system mistakenly attacks healthy cells in your central nervous system. It primarily damages the optic nerves and spinal cord, leading to symptoms like vision loss, weakness, and numbness. Early diagnosis and ongoing treatment are crucial to manage symptoms and prevent further attacks.

What is Neuromyelitis Optica?

Neuromyelitis optica (NMO) is a rare, chronic autoimmune disease where your immune system attacks healthy cells, mainly in the optic nerves and spinal cord. This damage can lead to vision problems, weakness, and other neurological issues. It was once called Devic's disease and often involves repeated attacks that can cause increasing disability over time.

NMO is considered an autoimmune disease, meaning your body's immune system, which normally fights off germs, mistakenly attacks its own healthy tissues. In NMO, the immune system targets specific cells in the central nervous system, particularly those in the optic nerves and spinal cord. This attack causes inflammation and damage. This condition is chronic, meaning it is a lifelong illness. It often follows a relapsing course, where periods of new or worsening symptoms (attacks or relapses) are followed by periods of recovery. However, each attack can cause new or increased damage, potentially leading to permanent disability. While NMO primarily affects the optic nerves and spinal cord, it can also impact other areas of the brain, including the brainstem and cerebellum. Understanding NMO is crucial because early and accurate diagnosis, along with consistent treatment, can help manage the disease and reduce the impact of attacks.

Symptoms

Symptoms of neuromyelitis optica (NMO) depend on which part of the central nervous system is affected, but commonly include sudden, painful vision loss (optic neuritis) and weakness, numbness, or paralysis in the limbs (transverse myelitis). Other symptoms can involve severe hiccups, nausea, vomiting, or problems with bladder and bowel control.

One of the most common symptoms is optic neuritis, which is inflammation of the optic nerve. This usually affects one eye at a time but can occur in both. Symptoms include eye pain, often made worse by eye movement, blurred vision, and partial or complete loss of vision. Some people also notice a loss of color vision. Another key symptom is transverse myelitis, which is inflammation of the spinal cord. This can cause weakness, numbness, or paralysis in the arms and legs. People may also experience muscle spasms, a tight, painful sensation around the chest or abdomen, and problems with bladder and bowel control, such as urgency or incontinence. If NMO affects the brainstem, symptoms can include persistent, uncontrollable hiccups or severe nausea and vomiting that doesn't go away. In some cases, NMO can affect other parts of the brain, leading to symptoms like confusion, seizures, excessive sleepiness (narcolepsy), or hormonal problems due to damage in areas like the hypothalamus.

Causes & risk factors

Neuromyelitis optica (NMO) is an autoimmune disease where the immune system mistakenly attacks a specific protein called aquaporin-4 (AQP4) in the central nervous system. The exact reason this attack starts is unknown, but it is more common in women, accounting for about 8 out of 10 cases, and often begins in people in their 30s and 40s.

The underlying cause of NMO is an autoimmune response. In most people with NMO, the immune system produces antibodies that target a protein called aquaporin-4 (AQP4). This protein acts as a water channel and is found on the surface of cells called astrocytes, which support nerve cells in the brain and spinal cord. When the immune system attacks AQP4, it damages these astrocytes, leading to inflammation and nerve damage. While we know what the immune system attacks, the exact reason why this autoimmune attack begins is not fully understood. It is believed to involve a combination of genetic predisposition and environmental factors, though specific triggers have not been definitively identified. There are certain risk factors associated with NMO. It is significantly more common in women than in men; about 8 out of 10 people (80%) diagnosed with NMO are women. The condition most often begins in people in their 30s and 40s, though it can affect individuals of any age, including children and older adults.

How it's diagnosed

Diagnosing neuromyelitis optica (NMO) involves a combination of a neurological exam, imaging tests like magnetic resonance imaging (MRI) of the brain, spinal cord, and optic nerves, and blood tests. A key blood test looks for a specific antibody called aquaporin-4 immunoglobulin G (AQP4-IgG), which is present in most people with NMO.

The diagnostic process typically begins with a thorough neurological exam. A doctor will assess your vision, strength, coordination, reflexes, and sensation to identify any signs of central nervous system damage. This helps to pinpoint which areas might be affected. Imaging tests are crucial. Magnetic resonance imaging (MRI) scans of the brain, spinal cord, and optic nerves are performed to look for characteristic lesions or areas of inflammation and damage. These scans can help distinguish NMO from other conditions that cause similar symptoms, such as multiple sclerosis. A blood test is a very important part of the diagnosis. It checks for the presence of an antibody called aquaporin-4 immunoglobulin G (AQP4-IgG), also known as NMO-IgG. This antibody is found in most, but not all, people with NMO. Its presence strongly supports an NMO diagnosis. In some cases, a lumbar puncture (spinal tap) may be performed to collect cerebrospinal fluid (CSF) for analysis, which can show signs of inflammation.

Treatment options

Treatment for neuromyelitis optica (NMO) focuses on managing acute attacks and preventing future relapses to minimize long-term damage and disability. Acute attacks are often treated with high-dose corticosteroids or plasma exchange. For long-term prevention, various immunosuppressant medications are used to calm the overactive immune system.

During an acute NMO attack, the primary goal is to reduce inflammation and limit damage. High-dose intravenous (IV) corticosteroids are often the first line of treatment. These powerful anti-inflammatory medications help to suppress the immune system's attack. If corticosteroids are not effective, or if the attack is severe, plasma exchange (PLEX) may be used. PLEX involves removing some of your blood, separating the plasma (the liquid part containing harmful antibodies), and returning the treated blood to your body. Long-term treatment is essential to prevent future attacks, which are a hallmark of NMO. Several medications are used to suppress the immune system and reduce the frequency and severity of relapses. These include immunosuppressants like azathioprine, mycophenolate mofetil, and rituximab. Newer, more targeted therapies, such as eculizumab, satralizumab, and inebilizumab, are also available and specifically designed to block parts of the immune system involved in NMO. In addition to medications that target the disease itself, treatment also includes managing symptoms. This can involve medications for pain, muscle spasms, or bladder dysfunction. Physical therapy, occupational therapy, and other rehabilitative services are also important to help people maintain function and improve their quality of life after an attack.

Recovery & outlook

The recovery and outlook for neuromyelitis optica (NMO) vary greatly among individuals, but it is a lifelong condition that typically involves repeated attacks. Each attack can cause new or worsening damage, potentially leading to permanent disability such as vision loss or paralysis. Early and ongoing treatment is vital to reduce the frequency and severity of attacks, helping to preserve function and improve quality of life.

NMO is a chronic condition, meaning it lasts a lifetime. Most people with NMO experience a relapsing course, where symptoms come and go, but each attack can leave behind new or increased neurological damage. This cumulative damage can lead to significant disability over time, including permanent vision loss, weakness, paralysis, and ongoing problems with bladder and bowel control. While there is no cure for NMO, the outlook has improved significantly with the development of effective treatments. Early diagnosis and consistent, long-term treatment to prevent relapses are crucial. By reducing the number and severity of attacks, treatments can help to minimize disability and preserve neurological function. Recovery from an attack can be partial or complete, but some residual symptoms or deficits are common. Rehabilitation therapies, such as physical and occupational therapy, play an important role in helping individuals regain strength, mobility, and independence. Managing NMO is a continuous process that requires close collaboration with a healthcare team to optimize treatment and support.

When to see a doctor

You should see a doctor immediately if you experience sudden vision changes, such as blurred vision, vision loss, or eye pain, especially if it's accompanied by weakness, numbness, or paralysis in your arms or legs. Other urgent signs include new or worsening problems with bladder or bowel control, or severe, persistent hiccups or nausea and vomiting.

It is important to seek prompt medical attention for any new or worsening neurological symptoms, as these could indicate an NMO attack. Early treatment during an attack can help reduce inflammation and potentially limit the amount of permanent damage. Specific symptoms that warrant immediate medical evaluation include: sudden onset of eye pain, blurred vision, or vision loss in one or both eyes; new or increasing weakness, numbness, or tingling in your arms or legs; or any new difficulty with walking or coordination. Additionally, if you experience new or worsening problems with bladder or bowel control, such as difficulty holding urine or stool, or if you develop severe, persistent hiccups or nausea and vomiting that does not resolve, you should contact your doctor right away. These symptoms could indicate an NMO relapse affecting critical areas of your central nervous system.

Frequently asked questions

Is neuromyelitis optica (NMO) the same as multiple sclerosis (MS)?

No, neuromyelitis optica (NMO) is not the same as multiple sclerosis (MS), although they share some similar symptoms and were once confused. NMO primarily targets the optic nerves and spinal cord, and often involves a specific antibody (AQP4-IgG) that is not typically found in MS. The underlying disease mechanisms and treatments also differ.

How rare is neuromyelitis optica (NMO)?

Neuromyelitis optica (NMO) is considered a rare disease. While exact numbers can vary by region, it affects a small number of people worldwide. Its rarity means that many healthcare providers may not encounter it frequently, highlighting the importance of consulting specialists experienced with the condition.

Can neuromyelitis optica (NMO) be cured?

Currently, there is no cure for neuromyelitis optica (NMO). It is a lifelong condition. However, treatments are available to manage acute attacks, reduce inflammation, and prevent future relapses. These treatments are crucial for minimizing long-term damage, preserving neurological function, and improving a person's quality of life.

What is the role of the AQP4 antibody in NMO?

The aquaporin-4 (AQP4) antibody plays a key role in most cases of NMO. It is an antibody produced by the immune system that mistakenly attacks the AQP4 protein, a water channel found on astrocytes in the central nervous system. This attack leads to inflammation and damage, causing the symptoms of NMO. Testing for this antibody helps confirm the diagnosis.

What is plasma exchange (PLEX) for NMO?

Plasma exchange (PLEX) is a treatment used for severe NMO attacks, especially if corticosteroids are not effective. During PLEX, a machine removes your blood, separates the plasma (the liquid part containing harmful antibodies), and then returns your blood cells along with a replacement fluid. This process helps to remove the antibodies that are attacking your central nervous system.

Can NMO affect children?

Yes, neuromyelitis optica (NMO) can affect children, although it is more commonly diagnosed in adults, typically in their 30s and 40s. When NMO occurs in children, it can present with similar symptoms to adult-onset NMO, and early diagnosis and treatment are equally important to manage the disease and prevent disability.

Sources

• MedlinePlus — Neuromyelitis Optica
• Mayo Clinic — Neuromyelitis Optica
• Cochrane Library — Neuromyelitis Optica